African Pharmaceutical Regulatory Intelligence

EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE

28 registrations across 4 African markets— 19 active

Markets with EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE

🇬🇭Ghana

Recent registrations

Brand / Product	Market	Holder	Status	Expires
Emjard M 5/500 Tablet Tablet	🇰🇪Kenya	Square Pharmaceuticals Ltd.	active	Jan 2030
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, COATED; ORAL	🇿🇼Zimbabwe	CIPLA LTD	active	Jun 2029
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, COATED; ORAL	🇿🇼Zimbabwe	CIPLA LTD	active	Jun 2029
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, COATED; ORAL	🇿🇼Zimbabwe	CIPLA LTD	active	Jun 2029
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, COATED; ORAL	🇿🇼Zimbabwe	CIPLA LTD	active	Jun 2029
GLIFEMPA XR Tablet	🇰🇪Kenya	GALAXY PHARMACEUTICAL LTD	active	Oct 2028
Jardimet 5/500 Tablet Film-Coated Tablet	🇰🇪Kenya	Beximco Pharmaceuticals Limited	active	Jun 2028
Synjardy 12.5 + 1000 mg Tablets Film-Coated Tablet	🇰🇪Kenya	Boehringer Ingelheim international GmbH	active	Nov 2027
Synjardy 5 / 850 mg Tablets Film-Coated Tablet	🇰🇪Kenya	Boehringer Ingelheim international GmbH	active	Oct 2027
Synjardy 5 / 1000 mg Tablets Film-Coated Tablet	🇰🇪Kenya	Boehringer Ingelheim international GmbH	active	Sept 2027
Synjardy 12.5 + 850 mg Tablets Film-Coated Tablet	🇰🇪Kenya	Boehringer Ingelheim international GmbH	active	Sept 2027
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 12.5mg/1000mg)	🇬🇭Ghana	—	expired	Jul 2026
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 12.5mg/1000mg)	🇬🇭Ghana	—	expired	Jul 2026
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 25mg/1000mg)	🇬🇭Ghana	—	expired	Jul 2026
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 10mg/1000mg)	🇬🇭Ghana	—	expired	Jul 2026
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 5mg/1000mg)	🇬🇭Ghana	—	expired	Jul 2026
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 10mg/1000mg)	🇬🇭Ghana	—	expired	Jul 2026
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 25mg/1000mg)	🇬🇭Ghana	—	expired	Jul 2026
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 5mg/1000mg)	🇬🇭Ghana	—	expired	Jul 2026
SYNJARDY TABLETS	🇬🇭Ghana	—	expired	Jun 2026
EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE ORAL SOLID ORDINARY OTHER TABLETS	🇺🇬Uganda	CIPLA LIMITED	active	—
EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE ORAL SOLID ORDINARY OTHER TABLETS	🇺🇬Uganda	CIPLA LTD.	active	—
EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE ORAL SOLID ORDINARY OTHER TABLETS	🇺🇬Uganda	CIPLA LIMITED	active	—
EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE ORAL SOLID ORDINARY OTHER TABLETS	🇺🇬Uganda	CIPLA LTD.	active	—
EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE ORAL SOLID ORDINARY OTHER TABLETS	🇺🇬Uganda	CIPLA LTD.	active	—
EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE ORAL SOLID ORDINARY OTHER TABLETS	🇺🇬Uganda	CIPLA LIMITED	active	—
EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE ORAL SOLID ORDINARY OTHER TABLETS	🇺🇬Uganda	CIPLA LTD.	active	—
EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE ORAL SOLID ORDINARY OTHER TABLETS	🇺🇬Uganda	CIPLA LIMITED	active	—

EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE in Africa — Regulatory Overview

EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE is registered across 4 African markets with 28 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda, Kenya, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 28 registrations, 19 (68%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.